Millennium Management LLC grew its position in shares of Nuvectra Corp (NASDAQ:NVTR) by 6.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 486,809 shares of the company’s stock after buying an additional 29,101 shares during the quarter. Millennium Management LLC’s holdings in Nuvectra were worth $7,954,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. PNC Financial Services Group Inc. grew its stake in shares of Nuvectra by 231.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,318 shares of the company’s stock valued at $54,000 after purchasing an additional 2,318 shares during the last quarter. Metropolitan Life Insurance Co. NY boosted its stake in Nuvectra by 356.5% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 5,108 shares of the company’s stock valued at $83,000 after acquiring an additional 3,989 shares during the last quarter. American International Group Inc. boosted its stake in Nuvectra by 23.5% in the fourth quarter. American International Group Inc. now owns 11,394 shares of the company’s stock valued at $186,000 after acquiring an additional 2,166 shares during the last quarter. GSA Capital Partners LLP bought a new position in Nuvectra in the third quarter valued at approximately $201,000. Finally, MetLife Investment Advisors LLC boosted its stake in Nuvectra by 57.1% in the third quarter. MetLife Investment Advisors LLC now owns 11,360 shares of the company’s stock valued at $250,000 after acquiring an additional 4,128 shares during the last quarter. 81.64% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:NVTR opened at $10.54 on Thursday. Nuvectra Corp has a 12 month low of $10.09 and a 12 month high of $25.17. The company has a debt-to-equity ratio of 0.47, a current ratio of 5.81 and a quick ratio of 5.48.

Nuvectra (NASDAQ:NVTR) last issued its quarterly earnings data on Thursday, February 28th. The company reported ($0.65) EPS for the quarter, topping analysts’ consensus estimates of ($0.80) by $0.15. Nuvectra had a negative net margin of 91.74% and a negative return on equity of 60.14%. The business had revenue of $14.53 million for the quarter, compared to analyst estimates of $15.58 million. On average, analysts expect that Nuvectra Corp will post -2.77 earnings per share for the current year.

Several equities research analysts have weighed in on the stock. BidaskClub lowered shares of Nuvectra from a “hold” rating to a “sell” rating in a report on Tuesday, February 26th. Raymond James cut their target price on shares of Nuvectra from $23.00 to $18.00 and set an “outperform” rating on the stock in a report on Friday, March 1st. Zacks Investment Research upgraded shares of Nuvectra from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a report on Tuesday, January 1st. Finally, ValuEngine lowered shares of Nuvectra from a “buy” rating to a “hold” rating in a report on Saturday, February 2nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $21.40.

WARNING: “Nuvectra Corp (NVTR) Shares Bought by Millennium Management LLC” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/nuvectra-corp-nvtr-shares-bought-by-millennium-management-llc/2955171.html.

About Nuvectra

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs.

Featured Article: What are no-load funds?

Want to see what other hedge funds are holding NVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nuvectra Corp (NASDAQ:NVTR).

Institutional Ownership by Quarter for Nuvectra (NASDAQ:NVTR)

Receive News & Ratings for Nuvectra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra and related companies with MarketBeat.com's FREE daily email newsletter.